Chembio Diagnostics, Inc.
CEMIDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001092662
Chembio Diagnostics, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on May 2, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $1.36M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Chembio Diagnostics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 72 | 60 | −12 |
| Shares | 6.98M | 4.85M | −2.13M (−30.5%) |
| Value | $24.5M | $14.4M | −$10.1M (−41.2%) |
New holders (13)
Institutions that held Chembio Diagnostics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tibra Equities Europe Ltd | 109,000 | $324.0K | 0.10% |
| Ergoteles LLC | 89,800 | $267.0K | 0.01% |
| Squarepoint Ops LLC | 65,509 | $195.0K | 0.00% |
| Occudo Quantitative Strategies LP | 58,441 | $174.0K | 0.03% |
| HRT Financial LP | 56,473 | $167.0K | 0.00% |
| Valmark Advisers, Inc. | 51,413 | $153.0K | 0.00% |
| Gsa Capital Partners LLP | 30,880 | $92.0K | 0.01% |
| Marshall Wace, LLP | 10,977 | $33.0K | 0.00% |
| Game Plan Financial Advisors, LLC | 11,000 | $33.0K | 0.02% |
| Schonfeld Strategic Advisors LLC | 10,800 | $32.0K | 0.00% |
| ExodusPoint Capital Management, LP | 10,672 | $32.0K | 0.00% |
| Jump Financial, LLC | 10,900 | $32.0K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (25)
Institutions that held Chembio Diagnostics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.